Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Roche will be making big changes in the organization of its employees, which is estimated to be around 100,000 in number. The company is taking this step as it implements new prioritization of the works.
Announcement of change in the workforce
As part of the plans, Roche will be eliminating 300 to 400 jobs this year. The affected employees will be the ones working at the company’s product development sites.
According to Reuters, the news about job cuts was announced by Levi Garraway, the firm’s chief medical officer. Through a video call with the employees, he directly told them what the company is planning to do.
"We have made the difficult decision to reduce our workforce in PD by around five to seven percent by the end of the year," he said. "And that equates to somewhere between 300 to 400 roles that will be impacted globally."
The company knows that this is a big blow to the affected workers, so Roche will try to lessen the impact by working with employees. It was not mentioned, though, how the company intends to help those who are about to lose their position.
Who are set to lose their jobs
Based on the information shared, the Roche employees that will be cut from the company are those who are in the product development units and working in the area of project management, business management, administrative support, project delivery, managers, and posts in learning and development.
The product development sites that will cut workers are located in Canada, Britain, United States, Switzerland, and China. Those who will be laid off are set to be notified between the months of August and October, and British employees are the first ones to go.
Felix Arellano, Roche’s head of global drug safety, admitted that this is the hardest thing that he had to do since he started working for the company. He was referring to the fact that he has to send off colleagues as they have been eliminated by the company, as per Fierce Biotech.
Finally, while Roche is cutting jobs, some of the other major pharmaceutical companies are looking for more workers. Most are building new factories, so they need to hire hundreds of workers.
